why choose us

First received: February 14, 2023

Clinical Trial: Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sickle Cell Disease

Study Type: INTERVENTIONAL


Official Title: A Feasibility Study on the Use of Plant Based Omega-3-Fatty Acids (Flaxseed) to Improve Inflammation Driven Pain Outcomes in Children With Sickle Cell Anemia

Brief Summary: Sickle cell disease (SCD) is associated with significant morbidity and mortality.Pain and many adverse outcomes occurring in sickle cell disease are inflammatory driven.Recent data has shown that gut dysbiosis is present in individuals with sickle cell disease.Gut dysbiosis has been linked to inflammation in certain diseases.Omega -3-fatty acids (fish oil) has been shown to improve pain outcomes in individuals with sickle cell disease, but its acceptance is variable.The aim of this study is to determine if a…

Read more